Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.
about
Small molecule suppressors of Drosophila kinesin deficiency rescue motor axon development in a zebrafish model of spinal muscular atrophyProtective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.Therapeutic strategies for the treatment of spinal muscular atrophy.SMN-inducing compounds for the treatment of spinal muscular atrophy.Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compoundsSmall Molecules in Development for the Treatment of Spinal Muscular Atrophy.Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbersCharacterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis.Spinal muscular atrophy: an update on therapeutic progressAntisense Oligonucleotide-Based Therapy for Neuromuscular Disease.Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCFSlmb degron.PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors.Axon outgrowth and neuronal differentiation defects after a-SMN and FL-SMN silencing in primary hippocampal cultures.
P2860
Q28536678-DDD76143-0332-46D3-A9C3-ED943D6ABF4DQ30743508-B694177A-85CE-44DC-98E2-408E8F3DBEDAQ34296140-A2703960-58FD-4645-B4C5-653CE75BF624Q34312156-F2E85C2A-A1B2-40C4-ABDC-68C42EB06560Q34760255-66AC32B1-DE8A-4314-95AB-B4C329683856Q36095048-1471045C-8E4E-4250-8C50-B6DED17969DCQ36484406-696DFD3C-FB12-46B4-98A0-E5ECC0D2AC5DQ36799584-22394EB0-2419-446E-898F-2F804C790375Q37184659-C2B567F8-32CC-47B9-A613-34243BF90AE7Q37302832-6C2992AE-1765-4FFD-8C8C-4B8FACD42E03Q38734734-2BD7AB5B-E8C8-4F08-BA49-BBD625EA6F89Q47372394-08FA4A2D-7F16-4521-A1DA-4E12C0545DC2Q54408272-545598A7-7012-4C50-B065-B090D1DB2B97Q55272773-CFE6648C-A573-402C-A7CB-3D6C97874913
P2860
Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@ast
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@en
type
label
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@ast
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@en
prefLabel
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@ast
Identification of a Maleimide- ...... el of Spinal Muscular Atrophy.
@en
P2093
P2860
P356
P1476
Identification of a Maleimide- ...... del of Spinal Muscular Atrophy
@en
P2093
Alan P Kozikowski
Bassem F El-Khodor
Nina R Makhortova
Sylvie Ramboz
P2860
P356
10.1021/CN200085Z
P577
2012-01-01T00:00:00Z